At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, ...

Jared Holz thought about taking one of the new GLP-1 drugs for weight loss for months ... loss come as shots that users give themselves once a week. “This has been really challenging,” Holz ...

Boasted as being a “breakthrough capsule formula designed to boost GLP-1 hormone levels, reduce hunger and cravings and ...

Once-weekly taspoglutide was superior to twice-daily ... and hypersensitivity reactions. Clearly, GLP-1 receptor agonists may not be appropriate for all patients with type 2 diabetes, as they ...

[18] There was no significant difference in weight change between any of the albiglutide dosings, with average weightloss being -1.1 to -1.7 ... to-head trial of once-weekly albiglutide and ...

The current state of weight-loss treatments is about to shift with the forthcoming availability of GLP-1 drugs in the ...

Mazdutide – a once-weekly injectable Innovent licensed from ... said Innovent. Novo Nordisk's GLP-1 agonist Ozempic (semaglutide) has been available in China for diabetes since 2021, and the ...

The results come just a few weeks after a once-weekly injectable GLP-1 drug CT-388 – also sourced from Carmot – achieved an average weight loss of 18.8% at 24 weeks in a phase 1b trial ...

In an unconventional alliance, North Carolina State Treasurer Dale Folwell, a Republican, spoke on Capitol Hill at a ...